-
Something wrong with this record ?
The healing dynamics of non-healing wounds using cryo-preserved amniotic membrane
A. Svobodova, V. Horvath, I. Smeringaiova, JV. Cabral, M. Zemlickova, R. Fiala, J. Burkert, D. Nemetova, P. Stadler, J. Lindner, J. Bednar, K. Jirsova
Language English Country England, Great Britain
Document type Journal Article
Grant support
NV18-08-00106
Ministerstvo Zdravotnictví Ceské Republiky
BBMRI_CZ LM2018125
Ministry of Education, Youth and Sport of the Czech Republic
Progres-Q25
Univerzita Karlova v Praze
NLK
Directory of Open Access Journals
from 2021
PubMed Central
from 2004
ProQuest Central
from 2021-02-01
Health & Medicine (ProQuest)
from 2021-02-01
Wiley-Blackwell Open Access Titles
from 2004
ROAD: Directory of Open Access Scholarly Resources
from 2004
PubMed
34791774
DOI
10.1111/iwj.13719
Knihovny.cz E-resources
- MeSH
- Amnion * MeSH
- Wound Healing * physiology MeSH
- Humans MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
We evaluated the effect of the application of cryo-preserved amniotic membrane on the healing of 26 non-healing wounds (18 patients) with varying aetiologies and baseline sizes (average of 15.4 cm2 ), which had resisted the standard of care treatment for 6 to 456 weeks (average 88.8 weeks). Based on their average general responses to the application of cryo-preserved AM, we could differentiate three wound groups. The first healed group was characterised by complete healing (100% wound closure, maximum treatment period 38 weeks) and represented 62% of treated wounds. The wound area reduction of at least 50% was reached for all wounds in this group within the first 10 weeks of treatment. Exactly 19% of the studied wounds responded partially to the treatment (partially healed group), reaching less than 25% of closure in the first 10 weeks and 90% at maximum for extended treatment period (up to 78 weeks). The remaining 19% of treated wounds did not show any reaction to the AM application (unhealed defects). The three groups have different profiles of wound area reduction, which can be used as a guideline in predicting the healing prognosis of non-healing wounds treated with a cryo-preserved amniotic membrane.
Department of Cardiovascular Surgery Motol University Hospital Prague Czech Republic
Department of Transplantation and Tissue Bank Motol University Hospital Prague Czech Republic
Department of Vascular Surgery Na Homolce Hospital Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22025045
- 003
- CZ-PrNML
- 005
- 20221031100201.0
- 007
- ta
- 008
- 221017s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/iwj.13719 $2 doi
- 035 __
- $a (PubMed)34791774
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Svobodova, Alzbeta $u 2nd Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 245 14
- $a The healing dynamics of non-healing wounds using cryo-preserved amniotic membrane / $c A. Svobodova, V. Horvath, I. Smeringaiova, JV. Cabral, M. Zemlickova, R. Fiala, J. Burkert, D. Nemetova, P. Stadler, J. Lindner, J. Bednar, K. Jirsova
- 520 9_
- $a We evaluated the effect of the application of cryo-preserved amniotic membrane on the healing of 26 non-healing wounds (18 patients) with varying aetiologies and baseline sizes (average of 15.4 cm2 ), which had resisted the standard of care treatment for 6 to 456 weeks (average 88.8 weeks). Based on their average general responses to the application of cryo-preserved AM, we could differentiate three wound groups. The first healed group was characterised by complete healing (100% wound closure, maximum treatment period 38 weeks) and represented 62% of treated wounds. The wound area reduction of at least 50% was reached for all wounds in this group within the first 10 weeks of treatment. Exactly 19% of the studied wounds responded partially to the treatment (partially healed group), reaching less than 25% of closure in the first 10 weeks and 90% at maximum for extended treatment period (up to 78 weeks). The remaining 19% of treated wounds did not show any reaction to the AM application (unhealed defects). The three groups have different profiles of wound area reduction, which can be used as a guideline in predicting the healing prognosis of non-healing wounds treated with a cryo-preserved amniotic membrane.
- 650 12
- $a amnion $7 D000650
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hojení ran $x fyziologie $7 D014945
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Horvath, Vojtech $u Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Smeringaiova, Ingrida $u Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Cabral, Joao Victor $u Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Zemlickova, Martina $u Clinic of Dermatovenerology, General Teaching Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Fiala, Radovan $u Department of Cardiovascular Surgery, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Burkert, Jan $u Department of Cardiovascular Surgery, Motol University Hospital, Prague, Czech Republic $u Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Nemetova, Denisa $u Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Stadler, Petr $u Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Lindner, Jaroslav $u 2nd Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Bednar, Jan $u Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Jirsova, Katerina $u Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Transplantation and Tissue Bank, Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000246256701
- 773 0_
- $w MED00180790 $t International wound journal $x 1742-481X $g Roč. 19, č. 5 (2022), s. 1243-1252
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34791774 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100159 $b ABA008
- 999 __
- $a ok $b bmc $g 1854645 $s 1176335
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 19 $c 5 $d 1243-1252 $e 20211117 $i 1742-481X $m International wound journal $n Int Wound J $x MED00180790
- GRA __
- $a NV18-08-00106 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a BBMRI_CZ LM2018125 $p Ministry of Education, Youth and Sport of the Czech Republic
- GRA __
- $a Progres-Q25 $p Univerzita Karlova v Praze
- LZP __
- $a Pubmed-20221017